glp 1 medication and ms You might know them as Ozempic, Wegovy, Mounjaro, Zepbound. GLP-1 receptor agonists are best known for managing diabetes and promoting weight loss, but researchers are discovering a wide spectrum of effective The GLP-1 revolution: What UAB

R.et al (2023)

Glutathione supports liver detox pathways active at night

Wegovy (semaglutide 2.4) and Zepbound (tirzepatide) are recent breakthroughs, enabling average weight losses of 1520% in clinical trials

patients had CKD stages 1 to 5 diagnosed by Kidney Disease: Improving Global Outcomes guidelines plus at least 3 months of one of the following: moderate to severe albuminuria regardless of estimated glomerular filtration rate (eGFR), eGFR less than 90 mL/min/1.73 m 2 with structural abnormalities of the kidney or urinary sediment abnormalities, or eGFR less than 60 mL/min/1.73 m 2 Efficacy End Points: Reduction in all-cause death, major adverse cardiovascular events (composite outcomes), and cardiovascular death